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Summary
Pseudomonas aeruginosa is a multi-host opportunis-
tic pathogen causing a wide range of diseases
because of the armoury of virulence factors it pro-
duces, and it is difficult to eradicate because
of its intrinsic resistance to antibiotics. Using an inte-
grated whole-genome approach, we searched for
P. aeruginosa virulence genes with multi-host rel-
evance. We constructed a random library of 57 360
Tn5 mutants in P. aeruginosa PAO1-L and screened it
in vitro for those showing pleiotropic effects in viru-
lence phenotypes (reduced swarming, exo-protease
and pyocyanin production). A set of these pleiotropic
mutants were assayed for reduced toxicity in
Drosophila melanogaster, Caenorhabditis elegans,
human cell lines and mice. Surprisingly, the screen-
ing revealed that the virulence of the majority of
P. aeruginosa mutants varied between disease
models, suggesting that virulence is dependent
on the disease model used and hence the host envi-
ronment. Genomic analysis revealed that these
virulence-related genes encoded proteins from
almost all functional classes, which were conserved
among P. aeruginosa strains. Thus, we provide
strong evidence that although P. aeruginosa is
capable of infecting a wide range of hosts, many of its
virulence determinants are host specific. These find-
ings have important implication when searching for
novel anti-virulence targets to develop new treat-
ments against P. aeruginosa.
Introduction
Pseudomonas aeruginosa is adapted to thrive in different
environments and is one of the top three causes of oppor-
tunistic human infections responsible for causing millions
of cases each year in the community and 10–15% of all
health care-associated infections (Lyczak et al., 2000;
Boucher et al., 2009). Various body sites may be affected
by P. aeruginosa infections including the respiratory tract,
skin and soft tissues, the urinary tract, post-operative and
burn wounds, brain, heart, bloodstream and cornea. Infec-
tions caused by this opportunistic pathogen are often
life threatening and they are of particular concern for
intensive care units where ventilated patients may develop
ventilator-associated pneumonia and sepsis (Gellatly and
Hancock, 2013). Other patients at risk of acquiring P.
aeruginosa are those with compromised immune system,
due to immunosuppressive therapies or underlying dis-
eases such as cancer, acquired immune deficiency syn-
drome (AIDS) or the hereditary disease cystic fibrosis (CF).
Antibiotics are used as the first line of action against
P. aeruginosa infections. However, the frequently
observed inefficacy of this type of treatment is linked to
the high levels of intrinsic and acquired resistance of
P. aeruginosa to these therapeutic agents (Poole, 2011).
Despite growing evidence about the severity of the
diseases caused by P. aeruginosa, no drugs with a
novel mechanism of action against this organism have
reached the market in recent years and all the other
registered drugs against Gram-negatives do not cover
Pseudomonas in their spectrum (Page and Heim, 2009).
Thus, there is an urgent need for the discovery of novel
alternative strategies to the traditional use of antibiotics
to combat P. aeruginosa infections. Anti-virulence
therapies have become an attractive approach that may
yield drugs with high specificity and narrow spectra
(Fernebro, 2011). These novel therapies are beginning to
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change the perspectives on infectious disease control.
Instead of reducing pathogen burden directly (‘pathogen
elimination’), anti-virulence therapies reduce the illness
caused by the pathogen (‘damage limitation’) (Vale et al.,
2014). From the perspective of the patient, reducing
illness is the first priority even before killing the cause.
During the past few years, remarkable progress has
been made in the identification of P. aeruginosa virulence
factors and the characterization of the mechanisms they
use to cause disease in the human host and a range of
disease models. Major P. aeruginosa virulence factors
have been identified at the single gene level by classical
genetics; that is, by searching for a mutant with a particu-
lar phenotype, followed by the identification of the
mutated gene and its characterization. Few studies have
used a genome-wide analysis through the screening of
P. aeruginosa mutant libraries (Liberati et al., 2006) in dif-
ferent non-vertebrate hosts including Caenorhabditis
elegans (Feinbaum et al., 2012) and Drosophila
melanogaster (Kim et al., 2008). Furthermore, high-
throughput screenings using transposon mutants tagged
with a unique oligonucleotide (e.g. signature tagged
mutagenesis) in vertebrate models including rats and
mice have been employed to identify virulence genes
involved in different stages of infection (e.g. acute or
chronic) (Potvin et al., 2003; Winstanley et al., 2009;
Bianconi et al., 2011). Early studies showed that the viru-
lence mechanisms used by P. aeruginosa to infect
phylogenetically diverse hosts were remarkably well con-
served, suggesting that the dissection of these mecha-
nisms in one single model system could provide reliable
understanding of the mechanisms used by P. aeruginosa
to cause disease in mammals (Finlay, 1999). Direct evi-
dence that P. aeruginosa uses a shared subset of viru-
lence factors to elicit disease has been provided first
comparing the plant Arabidopsis thaliana with mice
(Rahme et al., 1995), and thereafter extending the knowl-
edge to the nematode C. elegans (Tan et al., 1999),
the silkworm Bombyx mori (Chieda et al., 2005), the
insects Galleria melonella (Jander et al., 2000) and
D. melanogaster (Apidianakis and Rahme, 2009), the
amoeba Dictyostelium discoideum (Cosson et al., 2002)
and the zebrafish embryo (Phennicie et al., 2010). Limi-
tations of these studies are related to the restricted
number of P. aeruginosa strains tested, and the impact of
virulence in multi-host system by employing large high-
throughput screenings remains to be established.
The sequencing of the first P. aeruginosa genome in
2000 revealed that the PAO1 strain sequenced (now
PAO1-UW) has a genome size of 6.3 Mbp and contains
5570 predicted open reading frames (ORFs), making it
the largest bacterial genome sequenced at that time
(Stover et al., 2000). The large size of the P. aeruginosa
genome reflects the numerous and distinct gene families
that it contains, which is also a reflection of its ability to
adapt to many different environments. This is in contrast
to some other large bacterial genomes, whose size
reflects gene duplication events rather than greater
genetic and functional diversity. Specifically, the
P. aeruginosa genome contains a disproportionately large
number of genes predicted to encode outer membrane
proteins involved in adhesion, motility, antibiotic efflux,
virulence factor export and environmental sensing by
two-component systems (Kung et al., 2010). Additionally,
consistent with the metabolic versatility of this bacterium,
the P. aeruginosa genome has a large number of genes
encoding transport systems and enzymes involved
in nutrient uptake and metabolism. Considering the
genetic diversity of the P. aeruginosa genome, it is not
surprising that it contains one of the highest percentages
of predicted regulatory genes (8.4%) of all bacterial
genomes. Furthermore, the function of nearly 20% of the
P. aeruginosa genes has been demonstrated experimen-
tally (http://www.pseudomonas.com). The rest of the
P. aeruginosa genome has been assigned predicted func-
tions, based on homologies to previously characterized
genes, which remain to be demonstrated, with more than
500 genes remaining without annotation. Hence, there is
still a large amount of information missing with regard to
the mechanisms used by this organism to cause disease
and, as consequence, a whole array of anti-virulence
targets remains to be discovered within it.
As a first step toward selecting targets for anti-virulence
therapy, we constructed and screened a random library of
57 360 PAO1-L Tn5 mutants in vitro for pleiotropic effects
on virulence-related phenotypes (reduced swarming, exo-
protease and pyocyanin production) and for reduced tox-
icity in a sequential cascade of disease models, including
D. melanogaster, C. elegans, airways cell lines and finally
a murine model of acute pneumonia. Based on previous
knowledge reported above, it was expected that mutants
attenuated in one disease model would also show attenu-
ation in the other models. Surprisingly, the screening
revealed that pathogenicity of a set of P. aeruginosa
mutants behaved very differently in different disease
models suggesting that virulence is very much dependent
on the disease model used. Thus, we provide evidence that
although P. aeruginosa is capable of infection of a wide
range of hosts, many of the virulence determinants are
host specific.
Results
Genome-wide screening for P. aeruginosa
virulence-related genes in vitro and in C. elegans and
D. melanogaster disease models
Primary screen. The screening for virulence genes in
P. aeruginosa started with the construction of a Tn5
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mutant library in PAO1-L using pLM1 due to the high
transposition efficiency of this Tn5-based vector in
P. aeruginosa (Larsen et al., 2002) (Table S1). The overall
screening strategy is shown in Fig. 1A. A total of 57 360
Tn5 mutant strains (598 plates with 96 individual mutants
each), representing an estimated of 95% of the genome
(Liberati et al., 2006), were obtained by conjugation. A
high-throughput (HTP) screening using a robotic system
and suitable bioassays for the Tn5 mutants with attenu-
ated virulence were designed. Due to the large number of
mutants to be screened, the primary screening was not
done quantitatively for practical reasons. Thus, Tn5
mutants were tested individually in a qualitative manner
for attenuation in swarming, the loss of the blue pigment
Fig. 1. Schematic representation of the Tn5 mutants screening procedure in multi-host system.
A. The whole procedure consisted of the following steps, with the remaining number of candidates shown after each step: size of transposon
library tested (57 360 Tn5 mutants), primary screening (404 Tn5 mutants selected from in vitro screening and 275 from C. elegans and
D. melanogaster screening), secondary screening (28 Tn5 mutants selected for cell culture models). The final 8 candidates were tested for
virulence attenuation in a mouse pneumonia model.
B. Summary of the results of the in vitro screening. A total of 404 Tn5 mutants having pleiotropic phenotypes (impaired in protease, pyocyanin
and swarming motility) were selected from the primary screening and further tested in C. elegans and D. melanogaster disease models (C).
D. Summary of the results of the transposon library.
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pyocyanin in liquid media and the reduction in protease
production using 5% skimmed milk agar plates. A total
of 5623 Tn5 mutants with alterations in one of these
three phenotypes were subsequently re-screened for
attenuation in the other two phenotypes (Fig. 1B). A total
of 404 putative virulence-related Tn5 mutants showing
pleiotropic effects on the above phenotypes (Fig. 1B)
were selected for screening using the C. elegans and
D. melanogaster infection models. This approach enabled
further short listing of the Tn5 mutants prior to identifying
any redundancies and evaluating them in quantitative
disease assays. A total of 232 Tn5 mutants out of the 404
above were found to be attenuated in at least one of the
non-vertebrate disease models used, whereas 43 were
attenuated in both models (Fig. 1C). Interestingly, in the
D. melanogaster disease model, fewer mutants (19)
showed attenuation compared with C. elegans (213). The
275 attenuated mutants were further screened to identify
those showing growth differences in relation to the paren-
tal strain and which could in part be responsible for the
attenuation observed. From this screening, only 108
mutants showed no growth defects (data not shown) and
hence were selected further investigation. As part of the
validation of the screening strategy used, seven mutants
found attenuated in the initial HTP screening, but not in
C. elegans and D. melanogaster, were also included
(later found to have Tn5 insertions in mexA, pauB1, tgpA,
PA3448, PA3613, tufA and PA5156), hence the 115
mutants recorded in Fig. 1A. These control mutants
together with the remaining 108 mutants (of which 3
and 62 were only attenuated in D. melanogaster and
C. elegans, respectively, whereas 43 in both models)
were tested for alterations in swarming motility, and the
production of pyocyanin and alkaline protease. Although
the primary qualitative assay by HTP screening showed
that all the selected 115 putative virulence-related
mutants were attenuated in the three phenotypes, this
secondary quantitative assays showed that only 47 of
them were attenuated in all three virulence traits, 52 in two
traits and 16 in one trait (data not shown). These differ-
ences could be attributed to the intrinsic nature of the
assays used, from qualitative to quantitative, which may
have resulted in changes in certain variables such as
oxygen and nutrient availability.
Genome mapping, functional classification of
P. aeruginosa virulence-related genes and their
conservation by comparative genomic analysis
The exact Tn5 insertion site in the PAO1-L genome for
each of the 115 putative virulence-related mutants was
determined by sequencing the Tn5 flanking genomic
regions. These resulted in the mapping of the mutations
as well as the identification of some redundancies, which
were excluded from further screening. Single insertions
within a specific gene in 68 Tn5 mutants, representing
1.3% of the entire genome coding sequences (Stover
et al., 2000), and 4 single insertion in intergenic regions
(PA1030.1, PA4767-68, PA5202-03, PA5360-61) were
found (Fig. 1D). Table 1 shows the detailed results of the
72 Tn5 mutants selected, including also 7 mutants without
attenuation in non-mammalian models as described
before.
The 68 ORFs identified with Tn5 insertions encoded
proteins from almost all functional classes (Fig. S1):
hypothetical, unknown, unclassified proteins (25 genes),
transport of small molecules (7), carbon metabolism
and energy metabolism (5), translation and post-
transcriptional modification (4), amino acid metabolism
(3), transcriptional regulators (3), biosynthesis of
co-factors and prosthetic group (3), motility and attach-
ment (3), putative enzyme (3), cell wall/lipopolysaccharide
(LPS)/capsule (2), secretion and export (2), adaptation
and protection (2), DNA replication (2), transcription and
RNA process/degradation (1), secreted factors (1), mem-
brane protein (1) and nucleotide biosynthesis and
metabolism (1). From all the genes identified, some of
them had been previously demonstrated to be virulence
determinants in P. aeruginosa. The role of these genes
included antibiotic resistance (parR, phoR, mexA), biofilm
formation (pelG, pslJ, mucP and cupA3), virulence factor
delivery (tssA1, pilD, xcpT and plcH), regulation (pqsA,
pqsC, pvdQ, rpoS, crc, pilU and ptsP) and metabolism
(bphO and nagE) (Table 1), supporting the robustness of
the screening strategy used.
Next, the presence and level of conservation of the
virulence-related genes identified in this study were
determined in different P. aeruginosa strains and in
other bacteria. Using the PAO1-UW genome (http://
www.pseudomonas.com) as a reference, a predicted
amino acid sequence-based comparative analysis
for selected targets was carried out against six
P. aeruginosa-sequenced genomes (PA14, LESB58, PA7,
2192, C3719 and PACS2). Furthermore, conserva-
tion was also investigated against the genomes of
Escherichia coli K12 and Burkholderia cenocepacia
J2315 (Table S2). The majority of the selected targets (58)
were found conserved in all the six P. aeruginosa
genomes analysed, seven (PA0914, CupA3, PA3110,
PA3327, RpoS, PA4282, PA5548) were conserved in five
genomes, one (TufA) in four genomes and two (PA0823
and PA3867) only in three genomes. Ten targets were
highly conserved in B. cenocepacia J2315, with an iden-
tity higher than 60%, whereas 41 had no or poor (< 40%)
identity. Analysis against the E. coli K12 genome revealed
that only five targets were highly conserved, with an iden-
tity higher than 60%, whereas 34 have no or poor (< 40%)
identity. A homologue of tufA with very high identity
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(> 80%) at the protein level was found in both
B. cenocepacia J2315 and E. coli K12. The majority of the
selected targets showed no clear homologues in humans,
suggesting that they may be considered further for anti-
virulence therapy.
Pathogenicity of P. aeruginosa selected
virulence-related genes in human cell culture model
Secondary screen. To evaluate whether virulence attenu-
ation found in the in vitro and non-mammalian screenings
may be confirmed in mammalian cell models, 28 putative
virulence-related Tn5 mutants selected from the 72
shortlisted in the screenings described above (Table 1)
were tested in A549 pulmonary cell line. Data obtained so
far showed that Tn5 mutants behaved differently in differ-
ent model systems; thus for the secondary screening, we
selected mutants attenuated in at least one in vitro phe-
notypes and in either C. elegans or D. melanogaster or
both. Because all the Tn5 mutants showed a high level of
identity in all the P. aeruginosa strains analysed in silico
(Table S2), the level of targets conservation was not
used as a selection criterion. As part of the validation of
the screening strategy, four mutants not attenuated in
C. elegans and D. melanogaster (tgpA, PA3613, PA4265
and PA5156) were also included (Table 1). Thus, a total of
28 Tn5 mutants were tested for cell invasion and cytokine
[interleukin (IL)-8] production in the A549 cell line. From
the selected Tn5 mutants, 17 showed attenuation in both
mammalian cell assays, 7 were attenuated in one of them
and 4 in none (Table 1 and Fig. 2). These results suggest
that in many cases, the in vitro and non-mammalian
screenings are not predictive of virulence attenuation in
mammalian cell models.
Fig. 2. Invasion and IL-8 release in A549
cells of selected Tn-5 mutants.
(A) Invasion by antibiotic exclusion assay and
(B) IL-8 release by ELISA were determined in
A549 cells after infection with wild-type and
Tn5 mutants. Data, from three independent
experiments, are expressed as
mean ± standard error of the mean (SEM).
*P < 0.05, **P < 0.01, ***P < 0.001, Student’s
t-test.
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Quantitative virulence analysis of the selected
P. aeruginosa Tn5 mutants and their impact on a
murine model of pneumonia
As part of the secondary screening, quantitative and more
extensive virulence assays were carried out to validate
the results obtained so far in in vitro and non-mammalian
models in a selection of P. aeruginosa Tn5 mutants. Eight
Tn5 mutants were selected with the following criteria:
(i) mutations in genes with known (kdpB, pvdQ, bphO,
crc) and unknown function (PA3613, PA2414, PA4916,
PA5156) and (ii) attenuated in either C. elegans (pvdQ,
PA2414, bphO), D. melanogaster (PA4916) or both
(kdpB, crc) or not attenuated (PA3613, PA5156). As part
of the validation of the screening strategy, two mutants not
attenuated in C. elegans and D. melanogaster were also
included, one of which (PA3613) was not attenuated in the
mammalian cell models, whereas the other (PA5156) was
attenuated (Table 1). These P. aeruginosa mutants were
subjected to: (i) quantitative in vitro analysis for the
attenuation of virulence traits including biofilm formation,
(ii) determination of C. elegans and D. melanogaster
killing curves, and, finally, (iii) pathogenicity in murine
models (Fig. 1A). All the mutants tested showed a reduc-
tion in elastase production, especially at 16 h of growth,
although at different levels (Fig. 3A). The crc mutant
showed the lowest elastase levels, whereas the PA3613
mutant produced the most. With regard to pyoverdine, the
Fig. 3. In vitro phenotypic characterization of P. aeruginosa PAO1-L and selected targets. Eight Tn5 mutants (kdpB, PA2414, pvdQ, PA3613,
bphO, PA4916, PA5156, crc) were selected for further characterization.
A. Protease, elastase, pyocyanin and pyoverdine production was determined in supernatant from culture grown to stationary phase using
colorimetric assays. For twitching motility, cells were inoculated with a toothpick from an LB agar plate onto a twitching plate (tryptone broth
plus 1% agar). The diameter of the twitching zone was determined. Values of triplicate cultures are given.
B. Biofilm formation was assessed using a bioflux microfluidic channel. Biofilm cells were continuously grown in 10% LB at 37°C for a period
of 14 h. Left panel shows a confocal microscope picture of the biofilms and right panel the representation of the surface coverage for each
mutant. Standard deviations are based on the mean values of six images taken in random locations in the microfluidic channel.
C. For swarming and swimming motility, cells were inoculated from a 16 h LB culture onto swarming or swimming plates containing 0.5% or
0.3% agar respectively.
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highest decrease in the production of this siderophore
was shown by the pvdQ mutant with the PA3613 and
PA5156 mutants showing similar levels to the wt PAO1-L.
Twitching, swimming and swarming motility was also
tested in all mutants in relation to the wild type. The
PA3613 mutant showed no reduction in motility as antici-
pated. In contrast, the PA4916 and PA5332-crc mutants
showed a drastic reduction in all three forms of motility
(Fig. 3A and C). All the mutants tested showed a signifi-
cant reduction in the ability to form biofilms with the
PA3613 once more showing the least reduction (Fig. 3B).
The impact of the eight selected P. aeruginosa muta-
tions in non-vertebrate models was confirmed following
their hosts survival rates over a period of 72 h for
C. elegans (Fig. 4A) and 22 h for D. melanogaster
(Fig. 4B). The killing curves confirmed the results shown
in Table 1. Interestingly, three mutants, pvdQ, PA2414
and bphO, were strongly attenuated in the C. elegans
model, but only weakly or not at all in the D. melanogaster
model. The crc mutant was found to be the most attenu-
ated strain in both infection models.
The final validation of the attenuation observed in the in
vitro and non-mammalian hosts virulence assays in the
eight mutants selected (kdpB, pvdQ, bphO, crc, PA2414,
PA4916, PA5156, PA3613) was carried out by assaying
their levels of lethality in a murine model of acute lung
infection (Fig. 5). After having assessed the first lethal
dose [5 × 106 colony-forming units (CFU)] for PAO1-L in
C57BL/6NCrlBR mice (Fig. S2), the 8 Tn5 mutants were
compared (Fig. 5). PAO1-L was fully lethal within 36 h,
whereas the lethality of all the mutants tested was signifi-
cantly lower and temporally shifted, with the exception of
the PA3613 mutant (Fig. 5A). Based on survival curves,
pvdQ, bphO, PA4916, PA5156, crc were significantly
less lethal in mice when compared with PAO1-L.
Histopathological analysis showed that the wild-type
PAO1-L strain induced higher inflammation and more
severe lesions in comparison with the crc and pvdQ
mutants (Fig. 5B). The area infiltrated by inflammatory
cells by quantitative analysis was significantly higher in
the lungs infected with the wild-type PAO1-L than with the
mutant pvdQ (Fig. 5C).
Overall, our data indicated that virulence determinants
are host specific as evidenced by the summary of the
results obtained in different model systems in Fig. 6.
Discussion
This study set out to identify novel virulence genes in
P. aeruginosa using a multi-host screening strategy with
the ultimate goal of selecting for novel anti-virulence
targets. This strategy consisted on the initial screening of
Fig. 4. Virulence of P. aeruginosa PAO1-L
and selected targets in C. elegans and
D. melanogaster disease models. (A) Lethality
curves of 72 h in the C. elegans disease
model of eight selected Tn5 mutants (kdpB,
PA2414, pvdQ, PA3613, bphO, PA4916,
PA5156, crc); (B) 22 h lethality curves in
D. melanogaster. The results presented here
show the mean values and standard errors
calculated from three independent
experiments.
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a Tn5 library, constructed within the current study, using a
set of in vitro virulence assays to select mutants with
pleiotropic effects. The selected mutants were subse-
quently tested in a sequential fashion on non-mammalian
(e.g. D. melanogaster and C. elegans) and mammalian
(e.g. airways cell lines and mice) disease model systems.
Considering that P. aeruginosa has a variety of clinical
presentations and shows an extraordinarily broad host
range, different infection models would enable better
understanding of which genes are major contributors to
virulence and whether these genes are host dependent or
not. We considered this question worthy of investigation
because it seemed likely to us that the virulence factors of
an opportunistic multi-host pathogen might have a supe-
rior clinical relevance when compared with the virulence
factors of host-specific pathogens.
Previous studies on the identification of P. aeruginosa
virulence genes in vivo using different disease models
have provided important information on pathogenicity but
were limited to either the number of mutants tested or the
use of a single host. Genome-wide screening have been
carried out mainly in C. elegans (Feinbaum et al., 2012),
D. melanogaster (Kim et al., 2008), Dictyostelium amoeba
(Alibaud et al., 2008), mice (Bianconi et al., 2011) and rats
(Potvin et al., 2003) (Winstanley et al., 2009). Although in
the study with Dictyostelium they used a range of hosts
including this amoeba, D. melanogaster and mice, the
study only targeted a small proportion of the genome
as it was limited to a redundant mini-Tn5 mutant library
of 2500 clones in a lasR mutant clinical isolate, all of
which were tested in the amoeba model, but only 4 in
D. melanogaster and mice. In contrast the screening pre-
sented in this manuscript was much more extensive,
using a total of 57 360 Tn5 redundant mutants, represent-
ing an estimated 95% of the genome (Liberati et al., 2006)
with a total of 404 independent pleiotropic mutants found
attenuated in two or more virulence traits. It is well known
that P. aeruginosa isolates from different environments
and clinical settings show a heterogeneous in vitro pro-
duction of various known virulence factors. However,
Fig. 5. Virulence of P. aeruginosa PAO1-L
and selected targets in a mouse model of
acute lung infection in C57BL/6NCrl mice.
C57BL6/NCrl 8 weeks old purchased from
Charles River Laboratory were intratracheally
injected with 5 × 106 CFU of PAO1-L wild type
or mutants.
A. Survival was monitored up to 96 h. Two
independent experiments were pooled.
Statistical analysis was calculated for pair
wise comparisons between wild-type and
mutant strains. *P < 0.05, **P < 0.01,
***P < 0.001, Mantel–Cox test.
B. Lung histopathology was performed after
24 h from infection for wild-type PAO1-L,
pvdQ mutant and crc mutant.
C. Quantification of infiltrated areas as a
percentage of total tissue area with
mean ± SEM is shown. Statistical analysis
was calculated for pair wise comparisons
between wild-type and mutant strains.
***P < 0.001, Mann–Whitney.
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some P. aeruginosa virulence-associated factors, like
swarming motility, protease and pyocyanin production
have been found in most isolates (Tielen et al., 2011;
Mayer-Hamblett et al., 2014) and hence were selected in
this study for the in vitro screening, as they are also of
major relevance to infection. The pleiotropic mutants were
then tested for their ability to kill D. melanogaster and
C. elegans and a set of 108 attenuated mutants in puta-
tive virulence-related mutants (corresponding to 68
genes) identified. Mapping of the Tn5 insertion sites in
each of the mutants identified revealed multiple strains
with the mutation in the same gene, indicating that the
screen was saturating. The 68 virulence-related genes
found are broadly distributed across 16 functional classes
and conserved within P. aeruginosa strains of different
origin and in their majority across the Gram-negative
pathogens E. coli and B. cenocepacia. Furthermore,
practically all these virulence-related genes did not have
homologues in humans, which increases the chances of
the future identification of inhibitors with selected toxicity
for their gene products. The majority of the virulence-
related genes identified belonged to the functional cat-
egory of hypothetical, unknown and unclassified genes
(24 genes, 35.8% of the total), suggesting that there is still
a large proportion of unknown genes remaining to be
discovered within the unexplored part of the P. aeruginosa
genome. Our screening also identified a number of
mutants with insertions in genes already shown to be
required for virulence in P. aeruginosa supporting the
robustness of the screening method used in this study.
Some of these genes are known to be involved in antibi-
otic resistance, biofilm formation, motility, virulence
factors production and secretion, metabolism and quorum
sensing regulation. Only 10 genes already found in pre-
vious genome-wide screens were identified in the present
study. This limited overlap supports the idea of a bias
toward the disease model used. Of notice, the overlaps
found were only with screens carried out in C. elegans
(Feinbaum et al., 2012), mice (Bianconi et al., 2011) or
rats (Potvin et al., 2003; Winstanley et al., 2009); no
overlap with previous screens using D. melanogaster
(Kim et al., 2008) were identified, possibly due to the
differences between the P. aeruginosa strains used in
these studies. Nevertheless, as mentioned before, the
screening method presented in this manuscript favours
the identification of mutants with attenuated virulence in
multi-host systems rather than in a single host.
Similar to previous screens, in this study, a number of
genes involved in adaptation to environmental stress
were also identified. Those include a large number of
metabolic genes involved in the generation and transport
of precursor metabolites and energy (fdhE, ptsP, xdhB,
Fig. 6. Poor correlation of P. aeruginosa virulence between different model systems. Summary of the results obtained in vitro, C. elegans,
D. melanogaster, cell culture and mouse. Red indicates attenuation in virulence (at least one assay for in vitro and cell culture); blue indicates
non-attenuation.
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bphO, nqrB, nagE and PA2414), and genes involved in
DNA synthesis and modification (smpB, pdxA, PA3867,
PA3950 and PA4282). Interestingly, genes playing a part
in amino acid synthesis and metabolism were also iden-
tified (pauB1 coding for a D-amino acid oxidase, hisD
coding for a histidinol dehydrogenase, PA3139 coding for
a threonine-phosphate-decarboxylase). This could maxi-
mize the utilization of the amino acids present in different
environments such as those encountered in the CF lung
(Thomas et al., 2000). The identification of a number
of mutants in genes involved in biofilm formation (psl,
mucP and pelG), type IV and VI secretion systems (xcpT,
pilD and tssA1) and stress response (phoR, rpoS and
parR) also illustrate their importance for survival of
P. aeruginosa in the ‘host environment’.
It has recently been argued that to understand the
bacterial infection process, it is key to consider the meta-
bolic transactions taking place and not simply ignore the
metabolic genes identified in screenings searching for
virulence factors (de Lorenzo, 2015). These metabolic
processes vary from host to host and our manuscript
clearly supports this argument, because mutants in
certain metabolic genes show disease attenuation only in
specific hosts. Hence, the nutrients provided by different
environments are going to be key determinants in the
infection process.
Surprisingly, this study revealed that a set of above
mentioned P. aeruginosa virulence factors are not
involved in pathogenicity in multiple hosts. The most
striking difference was detected between the two non-
mammalian models used in our study where the majority
of virulence genes attenuated in C. elegans were not in
D. melanogaster (43 out of 72 genes, about 60%). Fur-
thermore, other discrepancies were found when compar-
ing virulence attenuation between A549 cells, C. elegans
and D. melanogaster. These results are quite surprising
because it has been described that there is conservation
between innate immune pathways in D. melanogaster,
C. elegans and mammals (Ferrandon et al., 2007;
Engelmann and Pujol, 2010).
Finally, while testing selected mutants in murine pneu-
monia models, the current study found agreement
between the presence or absence of attenuation for some
targets between C. elegans and mice (pvdQ, bphO, crc,
PA3613), whereas others showed different results in the
two models. PA2414 was attenuated in C. elegans but
not in mice, and PA4916 and PA5156 were attenuated
in the mouse model of acute infection but not in
C. elegans. Similarly, agreement was observed between
the presence or absence of attenuation for some targets
in D. melanogaster and mice (kdpB, pvdQ, PA2414,
PA3613, PA4916 and crc), whereas others showed differ-
ent results (bphO and PA5156). BphO was attenuated in
C. elegans, but not in mice, and PA5156 was attenuated
in the mouse model of acute infection, but not in
C. elegans. The data presented in this manuscript show
that virulence genes, which were identified in vitro or in
non-mammalian infection models, may not be relevant for
pathogenesis in mammalians (Fig. 6). Our results com-
plement recent findings by Hilker et al., (2015) in which
they showed that P. aeruginosa strains isolated from
human infections and the environment evoked a signifi-
cantly different virulence gradient in the lettuce, Galleria
mellonella and mice models. Interestingly they found that
some strains that had never been in contact with a human
host were more virulent in the disease models they used
than some of those isolated from human. Furthermore, in
line with the results of our manuscript, the degree of
virulence between the P. aeruginosa strains tested varied
enormously depending on the disease model used.
In the context of infections caused by P. aeruginosa,
virulence is mediated by a wide network of regulators that
sense the environment and the physiological state of the
cell and adjust the transcription of specific genes resulting
in significant phenotypic changes. The use of non-
mammalian infection models has several downsides
when compared with the mammalian host. These include
the differences in incubation temperatures and the lack of
specific target organs, key receptors and pathways, which
can not only alter the behaviour of the bacterial pathogen,
but also affect the knowledge extrapolation into the
human host. However, although rodents are the first
choice for understanding infectious diseases in humans,
screening a large amount of targets in mouse models is
not feasible. Despite the downsides described above,
non-mammalian models remain a useful surrogate hosts
for initial large-scale screening, but our results indicated
that final validation should be carried out always in mam-
malian hosts. Thus, a multifaceted bottleneck approach,
by using a sequential cascade of model systems, may be
essential for the selection of anti-virulence drug targets.
Whether the virulence targets identified in this study
will have a clinical relevance remains to be fully estab-
lished. The approach employed in this work, although
representing a step forward toward the understanding of
P. aeruginosa pathogenesis, does not totally reflect the
complex scenarios taking place in infected patients. It has
been recognized that genes required for pathogenicity in
one strain of P. aeruginosa may neither be required for nor
predictive of virulence in other strains (Lee et al., 2006). In
addition, several lines of evidence are transforming the
view of infectious diseases from strictly pathogen-centric
to the one incorporating the host environmental and the
genetic determinants that modulate immune responses
(Chapman and Hill, 2012). Thus, a wide combination of
P. aeruginosa strains from different origins and validation
in various disease models including mammalians are
ideally required when searching for novel virulence
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targets to gain a better understanding of the possible
impact they may have in the human host.
Conclusions
Overall, our data provide an important message to be
taken into consideration when searching for novel anti-
virulence targets to develop new treatments against
P. aeruginosa infections. P. aeruginosa virulence is a
highly complex, multifactorial process requiring the coor-
dinated activity of many bacterial gene products that pro-
duction and activity can significantly vary depending on
the infection model used and hence the host environment.
The idea of a core set of virulence factors common to all
infection models may only apply to a very limited number
of them. The spectrum of virulence factors that play a role
in a given host model depends on a wide range of factors
including the intrinsic characteristics of the site of infec-
tion, the type of the immune response and the phase of
infection. Many virulence factors from P. aeruginosa are
likely to play very distinct roles according to the sites of
infection, posing an even greater challenge for the devel-
opment of novel personalized therapeutics.
Experimental procedures
Ethics statement
Mice studies were conducted according to protocols
approved by the San Raffaele Scientific Institute (Milan, Italy)
Institutional Animal Care and Use Committee (IACUC) and
adhered strictly to the Italian Ministry of Health guidelines for
the use and care of experimental animals.
Bacterial strains, growth conditions, plasmids and
general DNA manipulation
The bacterial strains and plasmids used are listed in
Table S1. Escherichia coli and P. aeruginosa were routinely
cultured in Luria–Bertani (LB) at 37°C under vigorous shaking
(200 r.p.m.). Media were solidified with 1.8% agar. The anti-
biotics were added, when required, to final concentrations
of 20 μg ml−1 for gentamicin, 15 μg ml−1 for nalidixic acid
and 20 μg ml−1 for streptomycin. Tetracycline was added
into media at the final concentrations of 125 μg ml−1 for
P. aeruginosa and 10 μg ml−1 for E. coli.
Genomic DNA isolation was performed using a Wizard
Genomic DNA purification kit (Promega). Plasmid DNA iso-
lation was performed using a Qiagen Midi Kit. All other DNA
manipulation techniques including analysis, digestion, liga-
tion and introduction of DNA into host cells by electroporation
were performed as described by Sambrook and Russel
(2001).
Transposon mutagenesis
Transposon mutants were generated by mating
P. aeruginosa PAO1 obtained from D. Haas (Department of
Microbiology, University of Lausanne, Switzerland) (referred
to as PAO1-L) (Heurlier et al., 2003) with E. coli strain λpir
S17.1 carrying pLM1 derived from pRL27 (Larsen et al.,
2002). Pseudomonas aeruginosa mutants were selected by
plating on LB agar containing gentamycin (20 μg ml−1), strep-
tomycin (500 μg ml−1) and nalidixic acid (15 μg ml−1). After
incubation at 37°C for 16 h mutant colonies were picked
using a Flexis (Genomics Solutions) colony-picking robot.
Colonies were arrayed into 94-well plates containing 200 μl of
15% glycerol in LB. The microtitre plates were sealed using a
gas-permeable membrane (Corning), incubated at 37°C for
16 h and then stored at −80°C.
Mutant selection
The P. aeruginosa mutant strains were screened for altera-
tions in pyocyanin production, swarming motility and/or alka-
line protease activity by visual examination with the aid of the
colony picker described in the previous section, which was
programmed to replicate the bacterial cultures from 96-well
plates into Omni Trays (Fisher Scientific) containing various
solidified media: LB to assess pyocyanin production through
changes in blue coloration, swarming agar (Rampioni et al.,
2010), or LB containing 5% (w/v) of skimmed milk for deter-
mination of protease activity.
Quantitative assays for phenotypic alteration
Pyocyanin and pyoverdine production, protease and elastase
activity, motility and biofilm formation were evaluated as
described (Essar et al., 1990). Details are reported in the
Supporting information.
Transposon insertion location
To determine the transposon insertion point in the chromo-
some of the selected Tn5 mutants, total genomic DNA was
isolated and digested with EcoRI, which nucleotide sequence
is absent within pLM1. Digested genomic DNA fragments
were re-circularized and, upon electroporation in E. coli λpir
S17.1, selected for gentamicin resistance. DNA insert regions
flanking the Tn5 were sequenced using primers tpnRL17-1
(5′-AACAAGCCAGGGATGTAACG-3′) and tpnRL17-2 (5′-
CAGCAACACCTTCTTCACGA-3′), at the Biopolymer Syn-
thesis and Analysis Department, Queens Medical Centre,
Nottingham, UK. DNA sequence analysis was performed
using software packages provided by the National Centre for
Biotechnology Information BLAST network server.
C. elegans and D. melanogaster virulence assays
Nematode slow-killing assays were performed essentially as
previously described (Lorè et al., 2012). The D. melanogaster
disease model was used as previously described
(Apidianakis and Rahme, 2009). Details are reported in the
Supplementary information.
In silico analysis
Comparative protein sequence analysis was carried out
against the six sequenced genomes (PA14, LESB58, PA7,
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2192, C3719 and PACS2) of P. aeruginosa and against
E. coli K12 and B. cenocepacia J2315 in order to check for
the presence and conservation of virulence genes in other
P. aeruginosa genomes and in other bacterial species. The
BLASTP program from NCBI (http://blast.ncbi.nlm.nih.gov/
Blast.cgi?PAGE=Proteins) was used for protein homology
analysis by aligning the amino acid sequence of PAO1
against other genomes. Furthermore, genes identified in our
screen were then checked for their presence in the annotated
Virulence Factor Database (http://www.mgc.ac.cn/VFs/)
(Chen et al., 2005).
Cell culture, invasion assay and IL-8 secretion
The A549 (human type II pneumocytes) cell line was pur-
chased from ATCC CCL-185 and cultured as described
(Pirone et al., 2008). Bacteria invasion assay was performed
using Polymvxins B (100 μg ml−1) (Sigma) protection assay
with minor modifications (Bianconi et al., 2011) and as
detailed in the Supporting information. IL-8 secretion was
performed as reported previously (Bianconi et al., 2011).
Mouse model of acute P. aeruginosa infection
C57Bl/6NCrlBR male mice (20–22 g) were purchased from
Charles River Laboratories, Italy. Acute P. aeruginosa infec-
tion was performed as previously described (Lorè et al.,
2012) and detailed in the Supporting information. Histopa-
thology was performed according to standard procedures.
Statistical analysis
Results are presented as mean ± standard error of the mean
(SEM). Statistical calculations and tests were performed
using Student’s paired t-test, and Log rank Mantel–Cox test
in order to determine the significance of differences in means
between pairs.
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